These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37207009)

  • 1. Relationship between Hemoglobin Concentration at Admission with the Incidence of No-Reflow Phenomenon and In-Hospital Mortality in Acute Myocardial Infarction with Elevation of ST Segments in Patients who underwent Primary Percutaneous Coronary Intervention.
    Akbar KMA; Dharma S; Andriantoro H; Sukmawan R; Mangkuanom AS; Rejeki VG
    Int J Angiol; 2023 Jun; 32(2):106-112. PubMed ID: 37207009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
    Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the No-Reflow Group After Primary Percutaneous Coronary Intervention Due to ST-Segment Elevation Myocardial Infarction - Are There Sex Differences?
    Zachura M; Sadowski M; Kurzawski J; Piątek K; Gąsior M
    Cardiovasc Revasc Med; 2022 Apr; 37():97-101. PubMed ID: 34167912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Kurtul A; Acikgoz SK
    Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention.
    Yaylak B; Altıntaş B; Özcan KS; Akdeniz E; Avcı İ; Zeren G; Şimşek B; Karabay CY
    Postepy Kardiol Interwencyjnej; 2018; 14(4):383-390. PubMed ID: 30603028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of serum procalcitonin level with the no-reflow phenomenon after a primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Murat SN; Kurtul A; Celik IE; Duran M; Yarlioglues M; Kilic A; Elcik D
    Coron Artery Dis; 2016 Mar; 27(2):116-21. PubMed ID: 26709984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Khalfallah M; Maria DA; Allaithy A
    Glob Heart; 2022; 17(1):23. PubMed ID: 35586740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality.
    Del Turco S; Basta G; De Caterina AR; Sbrana S; Paradossi U; Taddei A; Trianni G; Ravani M; Palmieri C; Berti S; Mazzone A
    Int J Cardiol; 2019 Sep; 290():34-39. PubMed ID: 31079969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of the TIMI risk index on admission for predicting angiographic no-reflow after primary percutaneous coronary intervention in patients with STEMI.
    Acet H; Ertaş F; Akil MA; Bilik MZ; Aydin M; Polat N; Yildiz A
    Turk J Med Sci; 2016 Apr; 46(3):604-13. PubMed ID: 27513233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Heart Failure and Coronary Blood Flow in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: An Observational Cohort Study.
    Elkammash A; Abdelhamid M; Sobhy M; Zaki A; Sadaka M; Omoniyi ON; Alsinan M; Farahat RM; Al Sattouf A; Madi K
    Cureus; 2023 Dec; 15(12):e50340. PubMed ID: 38205479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ST2 in plasma is associated with post-procedural no-or-slow reflow after primary percutaneous coronary intervention in ST-elevation myocardial infarction.
    Søndergaard FT; Beske RP; Frydland M; Møller JE; Helgestad OKL; Jensen LO; Holmvang L; Goetze JP; Engstrøm T; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2023 Jan; 12(1):48-52. PubMed ID: 36355574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No-Reflow after PPCI-A Predictor of Short-Term Outcomes in STEMI Patients.
    Pantea-Roșan LR; Pantea VA; Bungau S; Tit DM; Behl T; Vesa CM; Bustea C; Moleriu RD; Rus M; Popescu MI; Turi V; Diaconu CC
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32932736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention.
    Badran HM; Fatah AA; Soltan G
    J Clin Transl Res; 2020 Jul; 6(1):20-26. PubMed ID: 32935070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.
    Şen Ö; Şen SB; Topuz AN; Topuz M
    Biomark Med; 2021 Oct; 15(15):1357-1366. PubMed ID: 34533051
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Quisi A; Alıcı G
    J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
    Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
    Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
    Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.